FDA Warning Letter — Changzhou Qianhong Biopharma Co., Ltd.

Case 398857 — FEI 3005275502

The FDA took a Warning Letter action against Changzhou Qianhong Biopharma Co., Ltd. on Jun 10, 2013 (Changzhou, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Changzhou Qianhong Biopharma Co., Ltd.
Date
Jun 10, 2013
Fiscal Year
2013
Product Type
Drugs
Center
CDER
Location
Changzhou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.